Vaccine boosts T cells that target pancreatic tumours

Efforts to tackle pancreatic cancer by harnessing immune cells have had limited success. A clinical trial reports promising results from testing a personalized approach to boosting immune responses to such tumours. Clinical trial tests a personalized approach to treat pancreatic cancer.

Saved in:
Bibliographic Details
Published in:Nature (London) 2023-06, Vol.618 (7963), p.37-38
Main Authors: Huff, Amanda L., Zaidi, Neeha
Format: Article
Language:English
Subjects:
631/250
631/67
692/308
Antigens
Cancer
Carcinoma, Pancreatic Ductal
Clinical trials
Humanities and Social Sciences
Humans
Immune response
Immune system
Immunology
Immunotherapy
Lymphocytes
Lymphocytes T
mRNA vaccines
multidisciplinary
Neoantigens
News And Views
Pancreatic cancer
Pancreatic Neoplasms - pathology
Patients
Science
Surgery
T-Lymphocytes
Tumors
Vaccines
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Efforts to tackle pancreatic cancer by harnessing immune cells have had limited success. A clinical trial reports promising results from testing a personalized approach to boosting immune responses to such tumours. Clinical trial tests a personalized approach to treat pancreatic cancer.
ISSN:0028-0836
1476-4687
DOI:10.1038/d41586-023-01526-8